Risk factors and outcome of COVID-19 in patients with hematological malignancies
Abstract Background Prognostic factors of poor outcome in patients with hematological malignancies and COVID-19 are poorly defined. Patients and methods This was a Spanish transplant group and cell therapy (GETH) multicenter retrospective observational study, which included a large cohort of blood c...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2020-08-01
|
| Serier: | Experimental Hematology & Oncology |
| Online adgang: | http://link.springer.com/article/10.1186/s40164-020-00177-z |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
